Rektum kanserinde neoadjuvan tedavi alan hastalarda total mezorektal eksizyon sonrası koruyucu ileostomi gerekliliği

Yıl 2014, Cilt: 24 Sayı: 3, 105 - 108, 01.01.2014

Süleyman Kargın Murat Çakır Tevfik Küçükkartallar Ahmet Tekin Ebubekir Gündeş M.sinan İyisoy

Öz

Amaç: Rektum kanseri için neoadjuvan kemoradyoterapi kullanımı hızla gelişmektedir. Neoadjuvan tedavilerdeki tüm gelişmelere karşın kemoradyoterapi alan hastalarda cerrahi sonrası komplikasyonlar ise hala tartışmalıdır. Çalışmamızın amacı rektum kanserinde neoadjuvan tedavi sonrası küratif cerrahi uygulanan hastalarda koruyucu ileostomi gerekliliğinin araştırılmasıdır. Gereç ve yöntemler: Kliniğimizde, neoadjuvan tedavi sonrası low anterior rezeksiyon ve total mezorektal eksizyon uygulanan rektum kanserli 19 hastanın verileri retrospektif olarak değerlendirildi. Ameliyat süresi, peroperatif ve postoperatif komplikasyonları, morbidite, mortalite ve hastade kalış süreleri ileostomi durumuna göre kıyaslandı. İstatistiksel analizde ki kare ve Mann Whitney U testleri kullanıldı. Bulgular: İleostomi açılan grupta anastomoz kaçağı 2 hastada görülürken açılmayan grupta 1 hastada anastomoz kaçağı gözlendi. Gruplar arasında postoperatif morbidite açısından anlamlı fark gözlenmedi. Komplikasyon ve hastanede kalış süreleri benzerdi. İleostomi açılmayan grupta ameliyat süresi daha kısaydı. Sonuç: Rektum kanserinde neoadjuvan tedavi sonrası küratif rezeksiyon yapılan hastalarda koruyucu ileostominin komplikasyonları ve morbiditeyi artırmadığını düşünmekteyiz. Ancak bu konunun daha geniş serilerde irdelenmesi gerekmektedir

Anahtar Kelimeler

Neoadjuvan tedavi, rektum kanseri, koruyucu ileostomi

Requirements of protective ileostomy after mesorectal excision in patients with rectal cancer who treated by adjuvant therapy

Öz

Objectives: The use of neoadjuvant chemoradiation for rectal cancer is developing rapidly. Despite all the advances in neoadjuvant therapy, complications after surgery is still controversial in patients who receiving chemoradiation. The aim of our study is to investi- gate the necessity of protective ileostomy after neoadjuvant therapy in rectal cancer patients who undergoing curative surgery. Mate- rial and methods: Data of 19 rectal cancer patients who were treaded with low anterior resection and total mesorectal excision after neoadjuvant therapy were evaluated retrospectively. Surgical operation time, intraoperative and postoperative complications, mor- bidity, mortality and length of stay in hospital were compared according to ileostomy state. Chi-square and Mann-Whitney U tests were used as statistical analysis. Results: Anastomotic leakage was seen two patients in ileostomy group while in other group leakage was seen one patient. No significant differences between the groups about postoperative morbidity was observed. Complications and length of hospital stay were similar. Surgery time was shorter in without ileostomy group. Conclusion: We believe that protective ileostomy after neoadjuvant therapy in rectal cancer patients who underwent curative resection, not increasing complications and morbidity. However, this issue needs to be evaluated in larger series

Anahtar Kelimeler

Neoadjuvant terapy, rectal cancer, protective ileostomy

Kaynakça

• Påhlman L. Optimal management of rectal cancer – is sphincter saving an important end-point? EJC Suppl 2005;65:365–9.
• Brown G, Richards CJ, Newcombe RG. Rectal carcinoma: thin-section MR imaging for staging in 28 patients. Radiology 1999;211:215–22.
• Hiotis SP, Weber SM, Cohen AM, et al. Assessing the predic- tive value of clinical complete response to neoadjuvant thera- py for rectal cancer: an analysis of 488 patients. J Am Coll Surg 2002;194:131-5; discussion 5-6.
• Gastinger I, Marusch F, Steinert R, et al. Protective defunction- ing stoma in low anterior resection for rectal carcinoma. Br J Surg 2005;92:1137-42.
• den Dulk M, Smit M, Peeters KC, et al. A multivariate analysis of limiting factors for stoma reversal in patients with rectal cancer entered into the total mesorectal excision (TME) trial: a retrospec- tive study. Lancet Oncol 2007;8:297-303.
• Rodriguez-Ramirez SE, Uribe A, Ruiz-Garcia EB, Labastida S, Lu- na-Perez P. Risk factors for anastomotic leakage after preoperative chemoradiation therapy and low anterior resection with total me- sorectal excision for locally advanced rectal cancer. Rev Invest Clin 2006;58:204-10.
• Bansal V, Bhutani R, Doval D, et al. Neo adjuvant chemo-radio- therapy and rectal cancer: can India follow the West? J Cancer Res Ther 2012;8:209-14.
• Janjan NA, Khoo VS, Abbruzzese J, et al. Tumor downstaging and sphincter preservation with preoperative chemoradiation in lo- cally advanced rectal cancer: the M. D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 1999;44:1027-38.
• Folkesson J, Nilsson J, Pahlman L, et al. The circular stapling device as a risk factor for anastomotic leakage. Colorectal Dis 2004;6:275–9.
• Buie WD, MacLean AR, Attard JA, et al. Neoadjuvant chemora- diation increases the risk of pelvic sepsis after radical excision of rectal cancer. Dis Colon Rectum 2005;48:1868–74.
• Wong NY, Eu KW. A defunctioning ileostomy does not prevent clinical anastomotic leak after a low anterior resection: a prospec- tive, comparative study. Dis Colon Rectum 2005;48:2076-9.
• Pappalardo G, Spoletini D, Proposito D, et al. Protective stoma in anterior resection of the rectum: when, how and why? Surg Oncol 2007;16 Suppl 1:S105-8.
• Hedrick TL, Sawyer RG, Foley EF, Friel CM. Anastomotic leak and the loop ileostomy: friend or foe? Dis Colon Rectum 2006;49:1167- 76.
• Law WI, Chu KW, Ho JW, Chan CW. Risk factors for anastomotic leakage after low anterior resection with total mesorectal excision. Am J Surg 2000;179:92-6.
• Pakkastie TE, Ovaska JT, Pekkala ES, Luukkonen PE, Jarvinen HJ. A randomised study of colostomies in low colorectal anastomoses. Eur J Surg 1997;163:929-33.
• Huser N,Michalski CW, Erkan M, et al. Systematic review and me- ta-analysis of the role of defunctioning stoma in low rectal cancer surgery. Ann Surg 2008;248:52-60.
• Bax TW, McNevin MS. The value of diverting loop ileosto- my on the high-risk colon and rectal anastomosis. Am J Surg 2007;193:585-7; discussion 7-8.
• Tilney HS, Sains PS, Lovegrove RE, et al. Comparison of outcomes following ileostomy versus colostomy for defunctioning colorectal anastomoses. World J Surg 2007;31:1142-51.